Page last updated: 2024-11-13

sch 419560

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Sch 419560: isolated from Pseudomonas fluorescens; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54710733
CHEMBL ID2204380
SCHEMBL ID17867169
MeSH IDM0425360

Synonyms (9)

Synonym
pseudopyronines b
420782-01-0
bdbm50401027
chembl2204380 ,
DTXSID10716145
6-heptyl-3-hexyl-4-hydroxy-2h-pyran-2-one
SCHEMBL17867169
6-heptyl-3-hexyl-4-hydroxyl-2h-pyran-2-one
sch 419560
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
3-oxoacyl-[acyl-carrier-protein] synthase 1Mycobacterium tuberculosis H37RvIC50 (µMol)3.80003.80003.80003.8000AID713916
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID1875611Antibacterial activity against Staphylococcus aureus ATCC12600 assessed as inhibition of bacterial growth by broth microdilution method2022Journal of natural products, 11-25, Volume: 85, Issue:11
Experimental and Computational Studies on the Biotransformation of Pseudopyronines with Human Cytochrome P450 CYP4F2.
AID1466843Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 measured after 24 hrs2017Bioorganic & medicinal chemistry letters, 06-15, Volume: 27, Issue:12
Isolation of the antibiotic pseudopyronine B and SAR evaluation of C3/C6 alkyl analogs.
AID713897Antimycobacterial activity against Mycobacterium tuberculosis H37Rv2012European journal of medicinal chemistry, Mar, Volume: 49Recent advances in antitubercular natural products.
AID1875612Antibacterial activity against Staphylococcus epidermidis ATCC14990 assessed as inhibition of bacterial growth by broth microdilution method2022Journal of natural products, 11-25, Volume: 85, Issue:11
Experimental and Computational Studies on the Biotransformation of Pseudopyronines with Human Cytochrome P450 CYP4F2.
AID1466840Antibacterial activity against Staphylococcus aureus ATCC 29213 measured after 24 hrs2017Bioorganic & medicinal chemistry letters, 06-15, Volume: 27, Issue:12
Isolation of the antibiotic pseudopyronine B and SAR evaluation of C3/C6 alkyl analogs.
AID1875615Antibacterial activity against Moraxella catarrhalis ATCC25238 assessed as inhibition of bacterial growth by broth microdilution method2022Journal of natural products, 11-25, Volume: 85, Issue:11
Experimental and Computational Studies on the Biotransformation of Pseudopyronines with Human Cytochrome P450 CYP4F2.
AID1601819Antimycobacterial activity against Mycobacterium tuberculosis H37Rv2019European journal of medicinal chemistry, Mar-01, Volume: 165Marine natural products as potential anti-tubercular agents.
AID1466841Antibacterial activity against Escherichia coli ATCC 15022 measured after 24 hrs2017Bioorganic & medicinal chemistry letters, 06-15, Volume: 27, Issue:12
Isolation of the antibiotic pseudopyronine B and SAR evaluation of C3/C6 alkyl analogs.
AID1875614Antibacterial activity against Streptococcus mutans ATCC25175 assessed as inhibition of bacterial growth by broth microdilution method2022Journal of natural products, 11-25, Volume: 85, Issue:11
Experimental and Computational Studies on the Biotransformation of Pseudopyronines with Human Cytochrome P450 CYP4F2.
AID1466842Antibacterial activity against Bacillus subtilis ATCC 11774 measured after 24 hrs2017Bioorganic & medicinal chemistry letters, 06-15, Volume: 27, Issue:12
Isolation of the antibiotic pseudopyronine B and SAR evaluation of C3/C6 alkyl analogs.
AID713916Inhibition of Mycobacterium tuberculosis H37Rv Fab12012European journal of medicinal chemistry, Mar, Volume: 49Recent advances in antitubercular natural products.
AID1875613Antibacterial activity against Pseudomonas aeruginosa ATCC15692 assessed as inhibition of bacterial growth by broth microdilution method2022Journal of natural products, 11-25, Volume: 85, Issue:11
Experimental and Computational Studies on the Biotransformation of Pseudopyronines with Human Cytochrome P450 CYP4F2.
AID1601834Inhibition of Mycobacterium tuberculosis InhA enzyme at 10 uM relative to control2019European journal of medicinal chemistry, Mar-01, Volume: 165Marine natural products as potential anti-tubercular agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.20 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (40.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]